These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22058079)

  • 21. Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy.
    Bovet P; Shamlaye C; Gabriel A; Riesen W; Paccaud F
    BMC Public Health; 2006 Jan; 6():9. PubMed ID: 16423280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomised controlled trial comparing uptake of NHS Health Check in response to standard letters, risk-personalised letters and telephone invitations.
    Gidlow CJ; Ellis NJ; Riley V; Chadborn T; Bunten A; Iqbal Z; Ahmed A; Fisher A; Sugden D; Clark-Carter D
    BMC Public Health; 2019 Feb; 19(1):224. PubMed ID: 30791884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary care and population factors associated with NHS Health Check coverage: a national cross-sectional study.
    Artac M; Dalton AR; Babu H; Bates S; Millett C; Majeed A
    J Public Health (Oxf); 2013 Sep; 35(3):431-9. PubMed ID: 23881962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost effectiveness of a community based exercise programme in over 65 year olds: cluster randomised trial.
    Munro JF; Nicholl JP; Brazier JE; Davey R; Cochrane T
    J Epidemiol Community Health; 2004 Dec; 58(12):1004-10. PubMed ID: 15547060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic appraisal of a community-wide cardiovascular health awareness program.
    Goeree R; von Keyserlingk C; Burke N; He J; Kaczorowski J; Chambers L; Dolovich L; Michael Paterson J; Zagorski B
    Value Health; 2013; 16(1):39-45. PubMed ID: 23337214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D).
    Saaristo T; Moilanen L; Jokelainen J; Korpi-Hyövälti E; Vanhala M; Saltevo J; Niskanen L; Peltonen M; Oksa H; Cederberg H; Tuomilehto J; Uusitupa M; Keinänen-Kiukaanniemi S
    Prim Care Diabetes; 2010 Dec; 4(4):231-9. PubMed ID: 21134669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The National Action Plan for the Prevention and Control of Non-communicable Diseases and Health Promotion in Pakistan--Cardiovascular diseases.
    Nishtar S; Faruqui AM; Mattu MA; Mohamud KB; Ahmed A
    J Pak Med Assoc; 2004 Dec; 54(12 Suppl 3):S14-25. PubMed ID: 15745323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of prevention on reducing the burden of cardiovascular disease.
    Kahn R; Robertson RM; Smith R; Eddy D
    Circulation; 2008 Jul; 118(5):576-85. PubMed ID: 18606915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of government subsidized pharmaceutical use in patients with diabetes or cardiovascular disease in a primary care setting: evidence from a prospective randomized trial.
    Hirst NG; Whitty JA; Synnott RL; Eley DS; Scuffham PA
    J Med Econ; 2011; 14(6):698-704. PubMed ID: 21892854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modelling the impact on avoidable cardiovascular disease burden and costs of interventions to lower SBP in the England population.
    Dodhia H; Phillips K; Zannou MI; Airoldi M; Bevan G
    J Hypertens; 2012 Jan; 30(1):217-26. PubMed ID: 22080224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of New Zealand CVD risk chart adjustments for family history and ethnicity on eligibility for treatment (PREDICT CVD-5).
    Wells S; Kerr A; Broad J; Riddell T; Kenealy T; Jackson R
    N Z Med J; 2007 Sep; 120(1261):U2712. PubMed ID: 17853933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in NHS primary dental care for older people in England: implications for the future.
    Kleinman ER; Harper PR; Gallagher JE
    Gerodontology; 2009 Sep; 26(3):193-201. PubMed ID: 19545327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
    Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
    Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NHS health checks through general practice: randomised trial of population cardiovascular risk reduction.
    Cochrane T; Davey R; Iqbal Z; Gidlow C; Kumar J; Chambers R; Mawby Y
    BMC Public Health; 2012 Nov; 12():944. PubMed ID: 23116213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing potential local routine monitoring indicators of reach for the NHS health checks programme.
    Lambert MF
    Public Health; 2016 Feb; 131():92-8. PubMed ID: 26715314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the uptake and delivery of the NHS Health Check programme in England, using primary care data from 9.5 million people: a cross-sectional study.
    Patel R; Barnard S; Thompson K; Lagord C; Clegg E; Worrall R; Evans T; Carter S; Flowers J; Roberts D; Nuttall M; Samani NJ; Robson J; Kearney M; Deanfield J; Waterall J
    BMJ Open; 2020 Nov; 10(11):e042963. PubMed ID: 33154064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the NHS Health Check on inequalities in cardiovascular disease risk: a difference-in-differences matching analysis.
    Chang KC; Vamos EP; Palladino R; Majeed A; Lee JT; Millett C
    J Epidemiol Community Health; 2019 Jan; 73(1):11-18. PubMed ID: 30282645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A qualitative study of cardiovascular disease risk communication in NHS Health Check using different risk calculators: protocol for the RIsk COmmunication in NHS Health Check (RICO) study.
    Gidlow CJ; Ellis NJ; Cowap L; Riley V; Crone D; Cottrell E; Grogan S; Chambers R; Clark-Carter D
    BMC Fam Pract; 2019 Jan; 20(1):11. PubMed ID: 30642267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
    Liew D; Park HJ; Ko SK
    Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.